Spatial Heterogeneity in Fatal Overdose Rate Trends in Mexican Cities: 2005-2021

Overview

Journal Am J Public Health

Specialty Public Health

Date 2024 May 9

PMID 38723222

Authors

Rosie Mae Henson

Pricila H Mullachery

Andres Sanchez-Pajaro

Copytzy Cruz-Cruz

Usama Bilal

Brent Langellier

Tonatiuh Barrientos-Gutierrez

Affiliations

Soon will be listed here.

Abstract

To describe national and city-level fatal drug overdose trends between 2005 and 2021 in Mexico. We calculated fatal overdose rates at the city level in 3-year periods from 2005 to 2021 and annually at the national level for people aged 15 to 64 years in Mexico. We calculated rate differences and rate ratios for each city between periods. The national fatal overdose rate was 0.53 overdose deaths per 100 000 population and was almost twice as high in urban than in nonurban areas. The national fatal overdose rate was stable over the period 2005 to 2014 and increased monotonically to a peak in 2021. Fatal overdose rates varied across cities. Cities with the 8 highest fatal overdose rates in the period were all in states along the US-Mexico border. Fatal overdoses have doubled over the past 15 years in Mexico. Overdose rates are particularly high and increasing in cities close to the US-Mexico border. There is a need for enhanced overdose surveillance data and coordinated harm reduction strategies, particularly in the northern border region of Mexico. (. 2024;114(7):705-713. https://doi.org/10.2105/AJPH.2024.307650).

Citing Articles

Urban Environments, Health, and Environmental Sustainability: Findings From the SALURBAL Study.

Diez Roux A, Alazraqui M, Alfaro T, Barrientos-Gutierrez T, Caiaffa W, Kroker-Lobos M J Urban Health. 2024; 101(6):1087-1103.

PMID: 39587001 PMC: 11652555. DOI: 10.1007/s11524-024-00932-1.

References

Borges G, Cherpitel C, Orozco R, Zemore S, Wallisch L, Medina-Mora M . Substance Use and Cumulative Exposure to American Society: Findings From Both Sides of the US-Mexico Border Region. Am J Public Health. 2015; 106(1):119-27. PMC: 4695949. DOI: 10.2105/AJPH.2015.302871. View

Clark A, Wilder C, Winstanley E . A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014; 8(3):153-63. DOI: 10.1097/ADM.0000000000000034. View

Fleiz C, Arredondo J, Chavez A, Pacheco L, Segovia L, Villatoro J . Fentanyl is used in Mexico's northern border: current challenges for drug health policies. Addiction. 2019; 115(4):778-781. DOI: 10.1111/add.14934. View

Diez Roux A, Slesinski S, Alazraqui M, Caiaffa W, Frenz P, Jordan Fuchs R . A Novel International Partnership for Actionable Evidence on Urban Health in Latin America: LAC-Urban Health and SALURBAL. Glob Chall. 2019; 3(4):1800013. PMC: 6450446. DOI: 10.1002/gch2.201800013. View

Bejarano Romero R, Sanchez-Lira J, Slim Pasaran S, Chavez Rivera A, Angulo Corral L, Salimian A . Implementing a decentralized opioid overdose prevention strategy in Mexico, a pending public policy issue. Lancet Reg Health Am. 2023; 23:100535. PMC: 10282171. DOI: 10.1016/j.lana.2023.100535. View

Goodman-Meza D, Friedman J, Kalmin M, Aguilar-Posada E, Seamans M, Velazquez-Moreno S . Geographical and socioeconomic disparities in opioid access in Mexico, 2015-19: a retrospective analysis of surveillance data. Lancet Public Health. 2021; 6(2):e88-e96. PMC: 7882061. DOI: 10.1016/S2468-2667(20)30260-7. View

Gonzalez-Nieto P, Salimian A, Arredondo J, Angulo L, Garcia de Loera A, Slim S . Intersections between syndemic conditions and stages along the continuum of overdose risk among women who inject drugs in Mexicali, Mexico. Harm Reduct J. 2023; 20(1):79. PMC: 10290314. DOI: 10.1186/s12954-023-00815-9. View

Goodman-Meza D, Medina-Mora M, Magis-Rodriguez C, Landovitz R, Shoptaw S, Werb D . Where Is the Opioid Use Epidemic in Mexico? A Cautionary Tale for Policymakers South of the US-Mexico Border. Am J Public Health. 2018; 109(1):73-82. PMC: 6301408. DOI: 10.2105/AJPH.2018.304767. View

Brouwer K, Case P, Ramos R, Magis-Rodriguez C, Bucardo J, Patterson T . Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Subst Use Misuse. 2006; 41(5):707-27. PMC: 2757051. DOI: 10.1080/10826080500411478. View

10.

Friedman J, Godvin M, Molina C, Romero R, Borquez A, Avra T . Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study. Drug Alcohol Depend. 2023; 249:110819. PMC: 10368172. DOI: 10.1016/j.drugalcdep.2023.110819. View

11.

Goodman-Meza D, Slim S, Angulo L, Gonzalez-Nieto P, Cambou M, Loera A . Impact of an overdose reversal program in the context of a safe consumption site in Northern Mexico. Drug Alcohol Depend Rep. 2023; 2:100021. PMC: 9948854. DOI: 10.1016/j.dadr.2021.100021. View

12.

West B, Abramovitz D, Gonzalez-Zuniga P, Rangel G, Werb D, Cepeda J . Drugs, discipline and death: Causes and predictors of mortality among people who inject drugs in Tijuana, 2011-2018. Int J Drug Policy. 2019; 75:102601. PMC: 6957706. DOI: 10.1016/j.drugpo.2019.11.009. View

13.

Volkmann T, Shin S, Garfein R, Patterson T, Pollini R, Wagner K . Border crossing to inject drugs in Mexico among injection drug users in San Diego, California. J Immigr Minor Health. 2011; 14(2):281-6. PMC: 3163238. DOI: 10.1007/s10903-011-9462-9. View

14.

Davis G, Cadwallader A, Fligner C, Gilson T, Hall E, Harshbarger K . Position Paper: Recommendations for the Investigation, Diagnosis, and Certification of Deaths Related to Opioid and Other Drugs. Am J Forensic Med Pathol. 2020; 41(3):152-159. DOI: 10.1097/PAF.0000000000000550. View

15.

Bilal U, Hessel P, Perez-Ferrer C, Michael Y, Alfaro T, Tenorio-Mucha J . Life expectancy and mortality in 363 cities of Latin America. Nat Med. 2021; 27(3):463-470. PMC: 7960508. DOI: 10.1038/s41591-020-01214-4. View

16.

Friedman J, Bourgois P, Godvin M, Chavez A, Pacheco L, Segovia L . The introduction of fentanyl on the US-Mexico border: An ethnographic account triangulated with drug checking data from Tijuana. Int J Drug Policy. 2022; 104:103678. PMC: 9169560. DOI: 10.1016/j.drugpo.2022.103678. View

17.

Bailey K, Abramovitz D, Patterson T, Harvey-Vera A, Vera C, Rangel M . Correlates of recent overdose among people who inject drugs in the San Diego/Tijuana border region. Drug Alcohol Depend. 2022; 240:109644. PMC: 9608984. DOI: 10.1016/j.drugalcdep.2022.109644. View

18.

Borges G, Zemore S, Orozco R, Cherpitel C, Martinez P, Wallisch L . Drug use on both sides of the US-Mexico border. Salud Publica Mex. 2018; 60(4):451-461. PMC: 6112603. DOI: 10.21149/8603. View

19.

Mullachery P, Rodriguez D, Miranda J, Lopez-Olmedo N, Martinez-Folgar K, Barreto M . Mortality amenable to healthcare in Latin American cities: a cross-sectional study examining between-country variation in amenable mortality and the role of urban metrics. Int J Epidemiol. 2021; 51(1):303-313. PMC: 8856009. DOI: 10.1093/ije/dyab137. View

20.

Martins S, Sampson L, Cerda M, Galea S . Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature. Am J Public Health. 2015; 105(11):e29-49. PMC: 4605170. DOI: 10.2105/AJPH.2015.302843. View